Arsenic Exposure and Epigenetic Alterations: Recent Findings Based on the Illumina 450K DNA Methylation Array

Current environmental health reports

Volumn 2, Issue 2, 2015, Pages 137-144

  Argos, Maria ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Arsenic exposure; DNA methylation; Environmental epidemiology; Epigenetics; Illumina 450K

Indexed keywords

ARSENIC; BIOLOGICAL MARKER;

ADVERSE EFFECTS; CHEMISTRY; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; DRUG EFFECTS; FEMALE; FETUS BLOOD; GENETIC EPIGENESIS; HUMAN; MATERNAL EXPOSURE; PROCEDURES;

ARSENIC; BIOMARKERS; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FETAL BLOOD; HUMANS; MATERNAL EXPOSURE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 85017113318     PISSN: None     EISSN: 21965412     Source Type: Journal    
DOI: 10.1007/s40572-015-0052-1     Document Type: Review

References (64)

1. IARC. http://www.inchem.org/documents/iarc/vol84/84-01-arsenic.html. 2004;84(39).
2. Argos M, Kalra T, Rathouz PJ, et al. Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. Lancet. 2010;376(9737):252–8.
3. Gilbert-Diamond D, Cottingham KL, Gruber JF, et al. Rice consumption contributes to arsenic exposure in US women. Proc Natl Acad Sci U S A. 2011;108(51):20656–60.
4. Xue J, Zartarian V, Wang SW, et al. Probabilistic modeling of dietary arsenic exposure and dose and evaluation with 2003–2004 NHANES data. Environ Health Perspect. 2010;118(3):345–50.
5. European Food Safety Authority. EFSA Panel on Contaminants in the Food Chain (CONTAM): scientific opinion on arsenic in food. EFSA Journal. 2009;7:1351.
6. Potera C. U.S. rice serves up arsenic. Environ Health Perspect. 2007;115(6):A296.
7. Jackson BP, Taylor VF, Karagas MR, et al. Arsenic, organic foods, and brown rice syrup. Environ Health Perspect. 2012;120(5):623–6.
8. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Arsenic, metals, fibres, and dusts. IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer. 2012;100(Pt C):11–465.
9. Abhyankar LN, Jones MR, Guallar E, et al. Arsenic exposure and hypertension: a systematic review. Environ Health Perspect. 2012;120(4):494–500.
10. Navas-Acien A, Sharrett AR, Silbergeld EK, et al. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol. 2005;162(11):1037–49.
11. Moon K, Guallar E, Navas-Acien A. Arsenic exposure and cardiovascular disease: an updated systematic review. Curr Atheroscler Rep. 2012;14(6):542–55.
12. Mazumder DN, Steinmaus C, Bhattacharya P, et al. Bronchiectasis in persons with skin lesions resulting from arsenic in drinking water. Epidemiology. 2005;16(6):760–5.
13. Parvez F, Chen Y, Yunus M, et al. Arsenic exposure and impaired lung function. Findings from a large population-based prospective cohort study. Am J Respir Crit Care Med. 2013;188(7):813–9.
14. Maull EA, Ahsan H, Edwards J, et al. Evaluation of the association between arsenic and diabetes: a national toxicology program workshop review. Environ Health Perspect. 2012. doi:10.1289/ehp.1104579.
15. Thayer KA, Heindel JJ, Bucher JR, et al. Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review. Environ Health Perspect. 2012;120(6):779–89.
16. Navas-Acien A, Silbergeld EK, Streeter RA, et al. Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ Health Perspect. 2006;114(5):641–8.
17. Rodriguez-Barranco M, Lacasana M, Aguilar-Garduno C, et al. Association of arsenic, cadmium and manganese exposure with neurodevelopment and behavioural disorders in children: a systematic review and meta-analysis. Sci Total Environ. 2013;454–455:562–77.
18. Rahman A, Vahter M, Ekstrom EC, et al. Association of arsenic exposure during pregnancy with fetal loss and infant death: a cohort study in Bangladesh. Am J Epidemiol. 2007;165(12):1389–96.
19. Huyck KL, Kile ML, Mahiuddin G, et al. Maternal arsenic exposure associated with low birth weight in Bangladesh. J Occup Environ Med. 2007;49(10):1097–104.
20. Agency for Toxic Substances and Disease Registry. The ATSDR 2011 substance priority list 2011 [cited 2013 May 31]. Available from: http://www.atsdr.cdc.gov/SPL/.
21. Bailey KA, Fry RC. Arsenic-associated changes to the epigenome: what are the functional consequences? Curr Environ Health Rep. 2014;1:22–34.
22. El-Osta A, Wolffe AP. DNA methylation and histone deacetylation in the control of gene expression: basic biochemistry to human development and disease. Gene Expr. 2000;9(1–2):63–75.
23. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003;349(21):2042–54.
24. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev. 2007;8(4):286–98.
25. Ziller MJ, Gu H, Muller F, et al. Charting a dynamic DNA methylation landscape of the human genome. Nature. 2013;500(7463):477–81.
26. McKay JA, Groom A, Potter C, et al. Genetic and non-genetic influences during pregnancy on infant global and site specific DNA methylation: role for folate gene variants and vitamin B(12). PLoS ONE. 2012;7(3):e33290.
27. Siedlinski M, Klanderman B, Sandhaus RA, et al. Association of cigarette smoking and CRP levels with DNA methylation in alpha-1 antitrypsin deficiency. Epigenetics. 2012;7(7).
28. Philibert RA, Plume JM, Gibbons FX, et al. The impact of recent alcohol use on genome wide DNA methylation signatures. Front Genet. 2012;3:54.
29. Lokk K, Modhukur V, Rajashekar B, et al. DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns. Genome Biol. 2014;15(4):r54.
30. Houseman EA, Accomando WP, Koestler DC, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 2012;13:86. This paper presents a novel statistical method for inferring leukocytes proportions based on a set of informative DNA methylation markers.
31. Pilsner JR, Liu X, Ahsan H, et al. Genomic methylation of peripheral blood leukocyte DNA: influences of arsenic and folate in Bangladeshi adults. Am J Clin Nutr. 2007;86(4):1179–86.
32. Pilsner JR, Liu X, Ahsan H, et al. Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ Health Perspect. 2009;117(2):254–60.
33. Majumdar S, Chanda S, Ganguli B, et al. Arsenic exposure induces genomic hypermethylation. Environ Toxicol. 2010;25(3):315–8.
34. Wilhelm CS, Kelsey KT, Butler R, et al. Implications of LINE1 methylation for bladder cancer risk in women. Clin Cancer Res. 2010;16(5):1682–9.
35. Lambrou A, Baccarelli A, Wright RO, et al. Arsenic exposure and DNA methylation among elderly men. Epidemiology. 2012;23(5):668–76.
36. Hossain MB, Vahter M, Concha G, et al. Environmental arsenic exposure and DNA methylation of the tumor suppressor gene p16 and the DNA repair gene MLH1: effect of arsenic metabolism and genotype. Metallomics. 2012;4(11):1167–75.
37. Tajuddin SM, Amaral AF, Fernandez AF, et al. Genetic and non-genetic predictors of LINE-1 methylation in leukocyte DNA. Environ Health Perspect. 2013. doi:10.1289/ehp.1206068.
38. Kile ML, Baccarelli A, Hoffman E, et al. Prenatal arsenic exposure and DNA methylation in maternal and umbilical cord blood leukocytes. Environ Health Perspect. 2012;120(7):1061–6.
39. Intarasunanont P, Navasumrit P, Waraprasit S, et al. Effects of arsenic exposure on DNA methylation in cord blood samples from newborn babies and in a human lymphoblast cell line. Environ Heal. 2012;11:31.
40. Pilsner JR, Hall MN, Liu X, et al. Influence of prenatal arsenic exposure and newborn sex on global methylation of cord blood DNA. PLoS ONE. 2012;7(5):e37147.
41. Chen WT, Hung WC, Kang WY, et al. Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase. Histopathology. 2007;51(6):785–92.
42. Zhang AH, Bin HH, Pan XL, et al. Analysis of p16 gene mutation, deletion and methylation in patients with arseniasis produced by indoor unventilated-stove coal usage in Guizhou, China. J Toxicol Environ Health. 2007;70(11):970–5.
43. Marsit CJ, Karagas MR, Danaee H, et al. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis. 2006;27(1):112–6.
44. Chanda S, Dasgupta UB, Guhamazumder D, et al. DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol Sci. 2006;89(2):431–7.
45. Engstrom KS, Hossain MB, Lauss M, et al. Efficient arsenic metabolism–the AS3MT haplotype is associated with DNA methylation and expression of multiple genes around AS3MT. PLoS ONE. 2013;8(1):e53732.
46. Ren X, McHale CM, Skibola CF, et al. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Perspect. 2011;119(1):11–9.
47. Reichard JF, Puga A. Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics. 2010;2(1):87–104.
48. Kile ML, Houseman EA, Baccarelli A, et al. Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood. Epigenetics. 2014;9(5). This study observed an association between prenatal arsenic exposure and cord blood DNA methylation, adjusting analyses for cell heterogeneity
49. Koestler DC, Avissar-Whiting M, Houseman EA, et al. Differential DNA methylation in umbilical cord blood of infants exposed to low levels of arsenic in utero. Environ Health Perspect. 2013;121(8):971–7. This study evaluated prenatal arsenic exposure on methylomic changes and is particularly informative for the analyses evaluating the genomic location as well as effect of arsenic on cell heterogeneity.
50. Rojas D, Rager JE, Smeester L, et al. Prenatal arsenic exposure and the epigenome: identifying sites of 5-methyl cytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2014. doi:10.1093/toxsci/kfu210. This study observed associations between prenatal arsenic exposure and cord blood DNA methylation, as well as evaluated functional evidence using gene expression data, and validation through disease outcomes.
51. Broberg K, Ahmed S, Engstrom K, et al. Arsenic exposure in early pregnancy alters genome-wide DNA methylation in cord blood, particularly in boys. J Dev Orig Health Dis. 2014;5(4):288–98. This study observed associations between prenatal arsenic exposure and cord blood DNA methylation among boys, showing sex-specific effects of arsenic on the methylome.
52. Smeester L, Rager JE, Bailey KA, et al. Epigenetic changes in individuals with arsenicosis. Chem Res Toxicol. 2011;24(2):165–7.
53. Seow WJ, Kile ML, Baccarelli AA, et al. Epigenome-wide DNA methylation changes with development of arsenic-induced skin lesions in Bangladesh: a case–control follow-up study. Environ Mol Mutagen. 2014;55(6):449–56. Although no significant associations were observed, this study employed a repeated assessment of DNA methylation to evaluate changes in methylation in relation to skin lesion incidence.
54. Bailey KA, Wu MC, Ward WO, et al. Arsenic and the epigenome: interindividual differences in arsenic metabolism related to distinct patterns of DNA methylation. J Biochem Mol Toxicol. 2013;27(2):106–15.
55. Liu X, Zheng Y, Zhang W, et al. Blood methylomics in response to arsenic exposure in a low-exposed US population. J Expo Sci Environ Epidemiol. 2014;24(2):145–9. Although no significant associations were observed, this study conducted a prospective analysis of arsenic exposure on subsequent DNA methylation alterations.
56. Argos M, Chen L, Jasmine F, et al. Gene-specific differential DNA methylation and chronic arsenic exposure in an epigenome-wide association study of adults in Bangladesh. Environ Health Perspect. 2015;123(1):64–71. This study observed associations between blood and urinary arsenic exposure and white blood cell DNA methylation, evaluated functional evidence using gene expression data, and replicated a subset of study findings in an independent cohort.
57. Yang TY, Hsu LI, Chiu AW, et al. Comparison of genome-wide DNA methylation in urothelial carcinomas of patients with and without arsenic exposure. Environ Res. 2014;128:57–63.
58. Rager JE, Bailey KA, Smeester L, et al. Prenatal arsenic exposure and the epigenome: altered microRNAs associated with innate and adaptive immune signaling in newborn cord blood. Environ Mol Mutagen. 2014;55(3):196–208.
59. Talens RP, Boomsma DI, Tobi EW, et al. Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology. FASEB J. 2010;24(9):3135–44.
60. Liang L, Cookson WO. Grasping nettles: cellular heterogeneity and other confounders in epigenome-wide association studies. Hum Mol Genet. 2014;23(R1):R83–8.
61. Reinius LE, Acevedo N, Joerink M, et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS ONE. 2012;7(7):e41361.
62. Houseman EA, Molitor J, Marsit CJ. Reference-free cell mixture adjustments in analysis of DNA methylation data. Bioinformatics. 2014;30(10):1431–9. This paper presents a novel statistical method for inferring cell type proportions for tissues (e.g., placenta, saliva, adipose or tumor tissue) where the relevant underlying cell types may not be known.
63. Winham SJ, Armasu SM, Cicek MS, et al. Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer. Genet Epidemiol. 2014;38(5):457–66.
64. Bjornsson HT, Sigurdsson MI, Fallin MD, et al. Intra-individual change over time in DNA methylation with familial clustering. JAMA. 2008;299(24):2877–83.